CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Abivax Sa Company Snapshot
Abivax Sa operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abivax Sa with three other miscellaneous service companies in Europe: Silence Therapeutics Plc of the United Kingdom (2014 sales of £15,000.00 [US$21,037.80 ] of which 100% was RNA therapeutics), Quantum Genomics SA (12,000.00 Euro [US$14,723.88 ] ), and Mologen AG which is based in Germany (12,000.00 Euro [US$14,723.88 ] of which 100% was Goods & Services).

Sales Analysis.
   
   
 
  Stock Performance Chart for Abivax Sa
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 7.50
(Figures in Euro)
1 Week 2.3%   13 Weeks -2.7%  
4 Weeks -16.0%   52 Weeks 8.4%  
 
Abivax Sa Key Data:
  Ticker: ABVX Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2014 Sales 14,488
(Year Ending Jan 2015).
Employees: 25
  Currency: Euro Market Cap: 72,514,418
  Fiscal Yr Ends: December Shares Outstanding: 9,668,589
  Share Type: Actions Ordinaires Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.